Robinson, N. B. et al. The current state of animal models in research: a review. Int. J. Surg. 72, 9–13 (2019).
Sung, H. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71, 209–249 (2021).
Jubber, I. et al. Epidemiology of bladder cancer in 2023: a systematic review of risk factors. Eur. Urol. 84, 176–190 (2023).
Saginala, K. et al. Epidemiology of bladder cancer. Med. Sci. 8, 15 (2020).
Kamat, A. M. et al. Bladder cancer. Lancet 388, 2796–2810 (2016).
Grabe-Heyne, K. et al. Intermediate and high-risk non-muscle-invasive bladder cancer: an overview of epidemiology, burden, and unmet needs. Front. Oncol. 13, 1170124 (2023).
Article PubMed PubMed Central Google Scholar
Patel, V. G., Oh, W. K. & Galsky, M. D. Treatment of muscle-invasive and advanced bladder cancer in 2020. CA Cancer J. Clin. 70, 404–423 (2020).
Siegel, R. L., Miller, K. D., Fuchs, H. E. & Jemal, A. Cancer statistics, 2022. CA Cancer J. Clin. 72, 7–33 (2022).
DeGraff, D. J. et al. Current preclinical models for the advancement of translational bladder cancer research. Mol. Cancer Ther. 12, 121–130 (2013).
Article CAS PubMed Google Scholar
Kobayashi, T., Owczarek, T. B., McKiernan, J. M. & Abate-Shen, C. Modelling bladder cancer in mice: opportunities and challenges. Nat. Rev. Cancer 15, 42–54 (2015).
Article CAS PubMed PubMed Central Google Scholar
Degoricija, M. et al. The dynamics of the inflammatory response during BBN-induced bladder carcinogenesis in mice. J. Transl. Med. 17, 394 (2019).
Article CAS PubMed PubMed Central Google Scholar
Cohen, S. M. Comparative pathology of proliferative lesions of the urinary bladder. Toxicol. Pathol. 30, 663–671 (2002).
Article CAS PubMed Google Scholar
Nabavizadeh, B., Amend, G. M. & Breyer, B. N. Workers died of dyes: the discovery of occupational bladder cancers. Urology 154, 4–7 (2021).
Case, R. A., Hosker, M. E., Mc, D. D. & Pearson, J. T. Tumours of the urinary bladder in workmen engaged in the manufacture and use of certain dyestuff intermediates in the British chemical industry. I. The role of aniline, benzidine, alpha-naphthylamine, and beta-naphthylamine. Br. J. Ind. Med. 11, 75–104 (1954).
CAS PubMed PubMed Central Google Scholar
Case, R. A. & Hosker, M. E. Tumour of the urinary bladder as an occupational disease in the rubber industry in England and Wales. Br. J. Prev. Soc. Med. 8, 39–50 (1954).
CAS PubMed PubMed Central Google Scholar
Barnes, J. M. & Magee, P. N. Some toxic properties of dimethylnitrosamine. Br. J. Ind. Med. 11, 167–174 (1954).
CAS PubMed PubMed Central Google Scholar
Magee, P. N. & Barnes, J. M. The production of malignant primary hepatic tumours in the rat by feeding dimethylnitrosamine. Br. J. Cancer 10, 114–122 (1956).
Article CAS PubMed PubMed Central Google Scholar
Druckrey, H., Preussmann, R., Schmähl, D. & Müller, M. Erzeugung von Blasenkrebs an Ratten mit N,N-Dibutylnitrosamin. Naturwissenschaften 49, 19 (1962).
Druckrey, H. et al. Selective induction of bladder cancer in rats by dibutyl- and N-butyl-N-butanol(4)-NITROSAMINE]. Z. Krebsforsch. 66, 280–290 (1964).
Article CAS PubMed Google Scholar
Akagi, G., Akagi, A., Kimura, M. & Otsuka, H. Comparison of bladder tumors induced in rats and mice with N-butyl-N-(4-hydroxybutyl)-nitrosoamine. Gan 64, 331–336 (1973).
Ito, N. et al. Effect of various carcinogenic and non-carcinogenic substances on development of bladder tumors in rats induced by N-butyl-N-(4-hydroxybutyl) nitrosoamine. Gan 65, 123–130 (1974).
Ito, N. Experimental urinary bladder tumors induced by N-butyl-N-(4-hydroxybutyl) nitrosamine. Gann Monogr. Cancer Res. 17, 367–381 (1975).
Hirose, M. et al. Different susceptibilities of the urinary bladder epithelium of animal species to three nitroso compounds. Gan 67, 175–189 (1976).
Ito, N., Hiasa, Y., Tamai, A., Okajima, E. & Kitamura, H. Histogenesis of urinary bladder tumors induced by N-butyl-N-(4-hydroxybutyl) nitrosamine in rats. Gan 60, 401–410 (1969).
Shirai, T. et al. Early surface changes of the urinary bladder epithelium of different animal species induced by N-butyl-N-(4-hydroxybutyl)-nitrosamine. Gan 68, 203–212 (1977).
Bertram, J. & Craig, A. Specific induction of bladder cancer in mice by butyl-(4-hydroxybutyl)-nitrosamine and the effects of hormonal modifications on the sex difference in response. Eur. J. Cancer 8, 587–594 (1972).
Fukushima, S., Hirose, M., Tsuda, H., Shirai, T. & Hirao, K. Histological classification of urinary bladder cancers in rats induced by N-butyl-n-(4-hydroxybutyl)nitrosamine. Gan 67, 81–90 (1976).
Fantini, D. et al. A carcinogen-induced mouse model recapitulates the molecular alterations of human muscle invasive bladder cancer. Oncogene 37, 1911–1925 (2018).
Article CAS PubMed PubMed Central Google Scholar
Okada, M. & Ishidate, M. Metabolic fate of N-n-Butyl-N-(4-hydroxybutyl)-nitrosamine and its analogues: selective induction of urinary bladder tumours in the rat. Xenobiotica 7, 11–24 (1977).
Article CAS PubMed Google Scholar
Lijinsky, W. & Epstein, S. S. Nitrosamines as environmental carcinogens. Nature 225, 21–23 (1970).
Article CAS PubMed Google Scholar
Ogawa, K. et al. Comparison of uroplakin expression during urothelial carcinogenesis induced by N-Butyl-N-(4-Hydroxybutyl)Nitrosamine in rats and mice. Toxicol. Pathol. 27, 645–651 (1999).
Ito, N., Shirai, T., Fukushima, S. & Hirose, M. Dose-response study of urinary bladder carcinogenesis in rats by N-butyl-N-(4-hydroxybutyl) nitrosamine. J. Cancer Res. Clin. Oncol. 108, 169–173 (1984).
Article CAS PubMed Google Scholar
Korac-Prlic, J., Degoricija, M., Vilovic, K., Vujevic, S. & Terzic, J. BBN-driven urinary bladder cancer mouse model. Methods Cell Biol. 163, 77–92 (2021).
Article CAS PubMed Google Scholar
Moore, C. M. et al. Mutagenic activation of dialkylnitrosamines by intact urothelial cells. Mutat. Res. 157, 95–105 (1985).
Article CAS PubMed Google Scholar
Nagao, M., Suzuki, E., Yasuo, K., Yahagi, T. & Seino, Y. Mutagenicity of N-butyl-N-(4-hydroxybutyl)nitrosamine, a bladder carcinogen, and related compounds. Cancer Res. 37, 399–407 (1977).
Airoldi, L., Magagnotti, C., Bonfanti, M. & Fanelli, R. Alpha-oxidative metabolism of the bladder carcinogens N-nitrosobutyl(4-hydroxybutyl)amine and N-nitrosobutyl(3-carboxypropyl)amine within the rat isolated bladder. Carcinogenesis 11, 1437–1440 (1990).
Article CAS PubMed Google Scholar
Nakanowatari, J., Fukushima, S., Imaida, K., Ito, N. & Nagase, S. Strain differences in N-butyl-N-(4-hydroxybutyl)nitrosamine bladder carcinogenesis in rats. Jpn. J. Cancer Res. 79, 453–459 (1988).
Article CAS PubMed PubMed Central Google Scholar
Irving, C. C. Oxidation of N-butyl-N-(3-formylpropyl)nitrosamine to N-butyl-N-(3-carboxypropyl)nitrosamine in rat liver and inhibition by disulfiram. Carcinogenesis 9, 2109–2112 (1988).
Article CAS PubMed Google Scholar
Airoldi, L., Magagnotti, C., De Gregorio, G., Moret, M. & Fanelli, R. In vitro metabolism of bladder carcinogenic nitrosamines by rat liver and urothelial cells. Chem. Biol. Interact. 82, 231–240 (1992).
Article CAS PubMed Google Scholar
Murai, T. et al. Differences in susceptibility to N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary bladder carcinogenesis between SD/gShi rats with spontaneous hypospermatogenesis and SD/cShi rats with spontaneous hydronephrosis. Cancer Sci. 96, 637–644 (2005).
留言 (0)